Skip to content
Clinical Trials – home

Centre Hospitalier Victor Dupouy

Verified siteinfo

France 69 Rue Du Lieutenant Colonel Prudhon, 95107 Argenteuil, France

  • 29 trials recruiting
  • Plasma cell myeloma · Sepsis · Pneumonia
  • Adults and children

About Specializations

Centre Hospitalier Victor Dupouy in Argenteuil, France specialises in clinical trials of conditions such as Plasma cell myeloma, Sepsis, Pneumonia, Acute myeloid leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology

The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for various blood disorders and cancers. The center's research includes groundbreaking studies on Chronic Lymphocytic Leukemia (CLL), Peripheral T-cell Lymphoma (PTCL), and Diffuse Large B Cell Lymphoma (DLBCL).

  • Chronic Lymphocytic Leukemia (CLL)
  • Peripheral T-cell Lymphoma (PTCL)
  • Diffuse Large B Cell Lymphoma (DLBCL)

Through clinical trials, the center is advancing the understanding of disease mechanisms and developing targeted therapies that improve patient outcomes.

Infectious Diseases and Critical Care

Specializing in infectious diseases and critical care, the center conducts pivotal research on conditions such as sepsis and ventilator-associated pneumonia. The research aims to enhance treatment protocols and patient management strategies in intensive care settings.

  • Sepsis
  • Ventilator-associated pneumonia
  • Sepsis-associated acute kidney injury

By integrating advanced therapeutic approaches, the center is improving survival rates and quality of care for critically ill patients.

Respiratory and Pulmonary Medicine

The center is a leader in respiratory and pulmonary medicine, with a focus on diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma. Research efforts are directed towards optimizing treatment regimens and exploring novel therapeutic options.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Severe Asthma
  • Severe Influenza Infection

Innovative clinical trials are paving the way for more effective management of respiratory conditions, enhancing patient quality of life.

Immunology and Autoimmune Disorders

Focusing on immunology and autoimmune disorders, the center is advancing research in conditions like immune thrombocytopenia (ITP) and polycythemia vera. The goal is to develop therapies that modulate the immune system to achieve better disease control.

  • Immune Thrombocytopenia (ITP)
  • Polycythemia Vera
  • Myelodysplastic Syndromes (MDS)

Through cutting-edge research, the center is contributing to the development of personalized medicine approaches for autoimmune conditions.

Cardiology and Vascular Medicine

The center's research in cardiology and vascular medicine includes studies on septic cardiomyopathy and thromboembolic events. The focus is on improving diagnostic and therapeutic strategies to enhance cardiovascular health.

  • Septic Cardiomyopathy
  • Thromboembolic Events
  • Vascular Health

By integrating novel research findings, the center is advancing the field of cardiovascular medicine, offering new hope for patients with complex vascular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
69 Rue Du Lieutenant Colonel Prudhon95107 ArgenteuilFrance
Recruiting now
29 trials
Conditions studied
60
Partner status
Verified site

More sites in ArgenteuilFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

82 clinical trials

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Asthma

Recruiting

Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Janssen Cilag International

A study to compare the effectiveness of EL219 against liposomal amphotericin B and voriconazole for patients with suspected invasive mould infections.

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amphotericin B
  • Sponsor:Elion Therapeutics Inc.

A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Assistance Publique Hopitaux De Paris

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Regeneron Pharmaceuticals Inc.

Sepsis

Recruiting

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris

Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tagraxofusp
  • Sponsor:French Innovative Leukemia Organization (F.I.L.O.).

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Intergroupe Francophone Du Myelome

Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Et Universitaire De Limoges

HIV infection

Recruiting

Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir
  • Sponsor:ANRS Maladies Infectieuses Emergentes
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.